Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circadian regulation of lung repair and regeneration
Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta
Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta
View: Text | PDF | Corrigendum
Research Article Pulmonology Virology

Circadian regulation of lung repair and regeneration

  • Text
  • PDF
Abstract

Optimal lung repair and regeneration are essential for recovery from viral infections, including influenza A virus (IAV). We have previously demonstrated that acute inflammation and mortality induced by IAV is under circadian control. However, it is not known whether the influence of the circadian clock persists beyond the acute outcomes. Here, we utilize the UK Biobank to demonstrate an association between poor circadian rhythms and morbidity from lower respiratory tract infections, including the need for hospitalization and mortality after discharge; this persists even after adjusting for common confounding factors. Furthermore, we use a combination of lung organoid assays, single-cell RNA sequencing, and IAV infection in different models of clock disruption to investigate the role of the circadian clock in lung repair and regeneration. We show that lung organoids have a functional circadian clock and the disruption of this clock impairs regenerative capacity. Finally, we find that the circadian clock acts through distinct pathways in mediating lung regeneration — in tracheal cells via the Wnt/β-catenin pathway and through IL-1β in alveolar epithelial cells. We speculate that adding a circadian dimension to the critical process of lung repair and regeneration will lead to novel therapies and improve outcomes.

Authors

Amruta Naik, Kaitlyn M. Forrest, Oindrila Paul, Yasmine Issah, Utham K. Valekunja, Soon Y. Tang, Akhilesh B. Reddy, Elizabeth J. Hennessy, Thomas G. Brooks, Fatima Chaudhry, Apoorva Babu, Michael Morley, Jarod A. Zepp, Gregory R. Grant, Garret A. FitzGerald, Amita Sehgal, G. Scott Worthen, David B. Frank, Edward E. Morrisey, Shaon Sengupta

×

Figure 5

Disruption of the circadian clock decreases proliferation after IAV infection.

Options: View larger image (or click on image) Download as PowerPoint
Disruption of the circadian clock decreases proliferation after IAV infe...
(A) SftpcCreERt2/+ Bmal1fl/fl mice, Cry1,2–DKO, and Scgb1a1Cre/+ Bmal1fl/fl and their creneg or WT littermates were moved to constant darkness (DD) 2 days prior to administering IAV at either CT23 or CT11. (B) Left: Representative Ki67-stained images from Scgb1a1Creneg Bmal1fl/fl mice and Scgb1a1Cre/+ Bmal1fl/fl littermates. Right: Quantification of Ki67+ cells/high power field (HPF). P = 0.0939 for genotype, P = 0.0091 for time of infection, and P = 0.0094 for interaction by 2-way ANOVA; **P = 0.0012 for creneg group and P > 0.999 for cre+ group with Bonferroni’s correction for multiple comparisons. (C) Left: SftpcCreERT2neg Bmal1fl/fl mice versus SftpcCreERt2/+ Bmal1fl/fl littermates. Right: Quantification of Ki67+ cells/HPF. P = 0.0314 for genotype, P = 0.0265 for time of infection, and P = 0.0035 for interaction by 2-way ANOVA; **P = 0.0030 for creneg group and P = 0.75 for cre+ group with Bonferroni’s correction for multiple comparisons. (D) Images and quantification Ki67+ AT2 cells in SftpcCreERT2neg Bmal1fl/fl and SftpcCreERt2/+ Bmal1fl/fl mice. (E) Cry1,2–DKO mice and quantification. *P = 0.0129 by unpaired 2-tailed t test. Each point represents an animal and data are expressed as mean ± SEM. Scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts